Return on Equity (ROE)
since 2005
Calculation
Abbott Laboratories, ROE, long-term trends, calculation
| ROE | = | 100 | × | Net earnings1 | ÷ | Total Abbott shareholders’ investment1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 14.83% | = | 100 | × | 5,723) | ÷ | 38,603) |
| Dec 31, 2022 | 18.90% | = | 100 | × | 6,933) | ÷ | 36,686) |
| Dec 31, 2021 | 19.75% | = | 100 | × | 7,071) | ÷ | 35,802) |
| Dec 31, 2020 | 13.71% | = | 100 | × | 4,495) | ÷ | 32,784) |
| Dec 31, 2019 | 11.86% | = | 100 | × | 3,687) | ÷ | 31,088) |
| Dec 31, 2018 | 7.76% | = | 100 | × | 2,368) | ÷ | 30,524) |
| Dec 31, 2017 | 1.54% | = | 100 | × | 477) | ÷ | 30,897) |
| Dec 31, 2016 | 6.82% | = | 100 | × | 1,400) | ÷ | 20,538) |
| Dec 31, 2015 | 20.85% | = | 100 | × | 4,423) | ÷ | 21,211) |
| Dec 31, 2014 | 10.61% | = | 100 | × | 2,284) | ÷ | 21,526) |
| Dec 31, 2013 | 10.23% | = | 100 | × | 2,576) | ÷ | 25,171) |
| Dec 31, 2012 | 22.32% | = | 100 | × | 5,963) | ÷ | 26,721) |
| Dec 31, 2011 | 19.35% | = | 100 | × | 4,728) | ÷ | 24,440) |
| Dec 31, 2010 | 20.66% | = | 100 | × | 4,626) | ÷ | 22,388) |
| Dec 31, 2009 | 25.14% | = | 100 | × | 5,746) | ÷ | 22,856) |
| Dec 31, 2008 | 27.92% | = | 100 | × | 4,881) | ÷ | 17,480) |
| Dec 31, 2007 | 20.28% | = | 100 | × | 3,606) | ÷ | 17,779) |
| Dec 31, 2006 | 12.22% | = | 100 | × | 1,717) | ÷ | 14,054) |
| Dec 31, 2005 | 23.39% | = | 100 | × | 3,372) | ÷ | 14,415) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
Comparison to Competitors
Abbott Laboratories, ROE, long-term trends, comparison to competitors
| Abbott Laboratories | Cigna Group | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 14.83% | 11.17% | 10.91% | 15.23% | 13.51% | 7.30% | 25.22% |
| Dec 31, 2022 | 18.90% | 14.86% | 5.84% | 16.59% | 11.98% | 9.59% | 25.87% |
| Dec 31, 2021 | 19.75% | 11.39% | 10.54% | 16.93% | 14.32% | 7.01% | 24.09% |
| Dec 31, 2020 | 13.71% | 16.81% | 10.35% | 13.77% | 10.90% | 9.44% | 23.52% |
| Dec 31, 2019 | 11.86% | 11.26% | 10.39% | 15.15% | 16.69% | 9.25% | 24.02% |
| Dec 31, 2018 | 7.76% | 6.43% | -1.02% | 13.14% | 16.89% | 6.12% | 23.19% |
| Dec 31, 2017 | 1.54% | 16.32% | 17.57% | 14.50% | 13.97% | 8.01% | 22.10% |
| Dec 31, 2016 | 6.82% | 13.60% | 14.44% | 9.84% | 12.74% | 6.80% | 18.33% |
| Dec 31, 2015 | 20.85% | 17.40% | 14.08% | 11.11% | 13.63% | 5.03% | 17.18% |
| Dec 31, 2014 | 10.61% | 19.51% | 12.23% | 10.60% | 12.39% | 15.76% | 17.31% |
| Dec 31, 2013 | 10.23% | 13.97% | 12.10% | 10.05% | 19.16% | 18.57% | 17.50% |
| Dec 31, 2012 | 22.32% | 16.61% | 10.28% | 11.16% | 18.34% | 21.14% | 17.72% |
| Dec 31, 2011 | 19.35% | 15.90% | 9.10% | 11.36% | 18.71% | 19.39% | 18.17% |
| Dec 31, 2010 | 20.66% | 20.24% | 9.09% | 12.12% | 18.74% | 21.18% | 17.94% |
| Dec 31, 2009 | 25.14% | 24.04% | 10.33% | 19.09% | 15.13% | 16.88% | 16.19% |
| Dec 31, 2008 | 27.92% | 8.13% | 9.29% | 11.62% | 16.13% | 19.34% | 14.33% |
| Dec 31, 2007 | 20.28% | 23.48% | 8.42% | 14.55% | 16.26% | 25.53% | 23.20% |
| Dec 31, 2006 | 12.22% | 26.67% | 13.80% | 12.59% | 12.22% | 27.14% | 19.99% |
| Dec 31, 2005 | 23.39% | 30.32% | 14.70% | 9.86% | 21.27% | 17.26% | 18.61% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Abbott Laboratories, ROE, long-term trends, comparison to sector (health care equipment & services)
| Abbott Laboratories | Health Care Equipment & Services | |
|---|---|---|
| Dec 31, 2023 | 14.83% | 15.01% |
| Dec 31, 2022 | 18.90% | 15.22% |
| Dec 31, 2021 | 19.75% | 14.90% |
| Dec 31, 2020 | 13.71% | 14.75% |
| Dec 31, 2019 | 11.86% | 13.92% |
| Dec 31, 2018 | 7.76% | 9.12% |
| Dec 31, 2017 | 1.54% | 13.43% |
| Dec 31, 2016 | 6.82% | 11.62% |
| Dec 31, 2015 | 20.85% | 12.65% |
| Dec 31, 2014 | 10.61% | 13.82% |
| Dec 31, 2013 | 10.23% | 13.68% |
| Dec 31, 2012 | 22.32% | 15.96% |
| Dec 31, 2011 | 19.35% | 14.82% |
| Dec 31, 2010 | 20.66% | 15.33% |
| Dec 31, 2009 | 25.14% | 17.11% |
| Dec 31, 2008 | 27.92% | 14.72% |
| Dec 31, 2007 | 20.28% | 16.83% |
| Dec 31, 2006 | 12.22% | 16.87% |
| Dec 31, 2005 | 23.39% | 16.99% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Abbott Laboratories, ROE, long-term trends, comparison to industry (health care)
| Abbott Laboratories | Health Care | |
|---|---|---|
| Dec 31, 2023 | 14.83% | 18.07% |
| Dec 31, 2022 | 18.90% | 22.47% |
| Dec 31, 2021 | 19.75% | 22.98% |
| Dec 31, 2020 | 13.71% | 16.02% |
| Dec 31, 2019 | 11.86% | 20.98% |
| Dec 31, 2018 | 7.76% | 17.71% |
| Dec 31, 2017 | 1.54% | 14.11% |
| Dec 31, 2016 | 6.82% | 18.09% |
| Dec 31, 2015 | 20.85% | 18.16% |
| Dec 31, 2014 | 10.61% | 18.60% |
| Dec 31, 2013 | 10.23% | 18.15% |
| Dec 31, 2012 | 22.32% | 17.49% |
| Dec 31, 2011 | 19.35% | 15.29% |
| Dec 31, 2010 | 20.66% | 14.41% |
| Dec 31, 2009 | 25.14% | 19.34% |
| Dec 31, 2008 | 27.92% | 18.87% |
| Dec 31, 2007 | 20.28% | 16.99% |
| Dec 31, 2006 | 12.22% | 20.34% |
| Dec 31, 2005 | 23.39% | 18.42% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).